Exciting new collaboration between the Huntington's Study Group (HSG) and Roche therapeutics. HSG will advise Roche on recruitment and enrollment of the needs of GENERATION HD2. This work will collectively advance therapeutic discoveries and improve the lives of HD patients.
Read the full press release here: https://www.pr.com/press-release/902369